The Ets-1 transcription factor is involved in pterygial angiogenesis

Journal of Veterinary Medicine Series C: Anatomia Histologia Embryologia

Volumn 36, Issue 2, 2007, Pages 107-110

  Naib Majani, W ^a,b   Breipohl, W ^a,b   Shazli, E E ^a,c   Theuerkauf, I ^a   Pleyer, U ^a,d   Hahne, J C ^a   Wernert, N ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Department of International Medical Education and Development ^*  (Germany)

^c RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1;

ADULT; AGED; ARTICLE; CORNEA; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; IN SITU HYBRIDIZATION; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PTERYGIUM; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADULT; AGED; CORNEA; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PTERYGIUM; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 33947275413     PISSN: 03402096     EISSN: 14390264     Source Type: Journal    
DOI: 10.1111/j.1439-0264.2006.00730.x     Document Type: Article

References (42)

1. Austin, P., F. Jakobiec, and T. Iwamoto, 1983: Elastodysplasia and elasto-dystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology 90, 96-109.
2. Boulukos, K. E., P. Pognonec, B. Rabault, A. Begue, and J. Ghysdael, 1989: Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol. Cell. Biol. 9, 5718-5721.
3. Butrus, S. I., M. F. Ashraf, D. Laby, A. Rabinowitz, S. O. Tabbara, and A. A. Hidayat, 1995: Increased numbers of Mast cells in pterygia. Am J. Ophthal. 119, 236-237.
4. Carmeliet, P., and D. Collen, 2000: Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann. N. Y. Acad. Sci. 902, 249-262; discusion 262-4.
5. Chen, J. K., R. Tsai, and S. Lin, 1994: Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev. Biol. Anim. 30, 243-248.
6. Coroneo, M. T., 1993: Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br. J. Ophthalmol. 77, 734-739.
7. Coster, D., 1995: Pterygium: an ophthalmic enigma. Br. J. Ophthalmol. 48, 143-147.
8. Delannoy-Courdent, A., V. Mattot, V. Fafeur, W. Fauquette, I. Pollet, T. Calmels, C. Vercamer, B. Boilly, B. Vandnbunder, and X. Desbiens, 1998: The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J. Cell Sci. 111, 1521-1534.
9. Girolamo, N., P. Mc Cluskey, A. Lloyd, M. T., Coroneo, and D. Wakefield, 2000: Expression of MMPs and TIMMPs in human pterygia and cultured pterygium epithelial cells. Invest. Ophthalmol. Vis. Sci. 41, 671-679.
10. Dushku, N., and T. W. Reid, 1994: Immunohistochcmical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr. Eye Res. 13, 473-481.
11. Dushku, N., and T. W. Reid, 1997: P53 expression in altered limbal basal cells of pingueculae, pterygia and limbal tumors. Curr. Eye Res. 16, 1179-1192.
12. Dushku, N., M. K. John, G. S. Schultz, and T. W. Reid, 2001: Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch. Ophthalmol. 119, 695-706.
13. Gilles, F., M. B. Raes, D. Stehelin, B. Vandenbunder, and V. Fafeur, 1996: The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. Exp. Cell. Res. 222, 370-378.
14. Hashiya, N., N. Jo, M. Aoki, K. Matsumoto, T. Nakamura, Y. Sato, N. Ogata, T. Ogihara, Y. Kaneda, and R. Morishita, 2004: In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesiscascade. Circulation 109, 3035-3041.
15. Hill, J. C., and R. Maske, 1989: Pathogenesis of pterygium. Eye 3, 218-226.
16. Ioachim-Velogianni, E., E. Tsironi, N. Agnantis, G. Datseris, and K. Psilas, 1995: HLA-DR antigen expression in pterygium epithelial cells and lymphocyte sub-populations: an immunhistochemistry study. Ger. J. Ophthal. 4, 123-129.
17. Iwasaka, C., K. Tanaka, M. Abe, and Y. Sato, 1996: Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cell Physiol. 169, 522-531.
18. Lelievre, E., F. Lionneton, and F. Soncin, 2001a: Role of the ETS transcription factors in the control of endothelial-specific gene expression and in angiogenesis. Bull. Cancer 88, 137-142.
19. Lelievre, E., F. Lionneton, F. Soncin, and B. Vandenbunder, 2001b: The Ets family contains transcriptional activators and repressers involved in angiogenesis. Int. J. Biochem. Cell Biol. 33, 391-407.
20. Li, D. Q., S. B. Lee, Z. Gunja-Smith, Y. Liu, A. Solomon, D. Meller, and S. C. Tseng, 2001: Over-expression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch. Ophthalmol. 119, 71-80.
21. McDonnell, J. M., A. J. Mayr, and W. J. Martin, 1989: DNA of human papilloma-virus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. New Engl. J. Mod. 320, 1442-1446.
22. Moran, D. J., and F. C. Hollows, 1984: Pterygium and ultraviolet radiation: a positive correlation. Br. J. Ophthalmol. 68, 343-346.
23. Naib-Majani, W., I. Eltohami, N. Wernert, H. Tschesche, U. Pleyer, and W. Breipohl, 2004: Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study. Graefe's Arch. Clin. Exp. Ophthalmol. 242, 332-338.
24. Nakamura, Y., S. Esnault, T. Maeda, E. A. Kelly, J. S. Malter, and N. N. Jarjour, 2004: Ets-1 regulates TNF-alpha-induced matix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts. J. Immunol. 172, 1945-1952.
25. Panchapakesan, J., F. Hourihan, and P. Mitchell, 1998: Prevalence of pterygium and pinguecula: The Blue Mountains Eye Study. Aust. N. Z. J. Ophthalmol. 26, 2-5.
26. Pardanaud, L., and F. Dieterlen-Lievre, 1993: Expression of C-ETS1 in early chick embryo mesoderm: relationship to the hemangioblastic lineage. Cell Adhes. Commun. 1, 151-160.
27. Paulsen, F., U. Schudig, T. Pufe, K. Recker, B. Nölle, K. Al-Samir, G. Geerling, A. Thale, and M. Gebardt, 2004: VEGF in pterygium: hints to a limbal origin. 102nd DOG Annual Meeting, Berlin, Germany.
28. Pinkerton, O. D., Y. Hokama, and L. A. Shigemura, 1984: Immunologic basis for the pathogenesis of pterygium. Am. J. Ophthalmol. 98, 225-228.
29. Powers, M. R., Z. Qu, B. O'Brien, D. J. Wilson, J. E. Thompson, and J. T. Rosenbaum, 1997: Immunolocalization of bFGF in pterygia: association with Mast cells. Cornea 16, 545-549.
30. Rohrbach, J. M., S. Stare, and M. Knorr, 1995: Vorhersage von Peterygium-rezidiven aufgrund morphologischer und immunhistologischer Parameter. Ophthalmology 92, 463-468.
31. Schellenbeck, M., N. Anders, J. S. Jürgensen, C. Hartmann, and H. Baatz, 2000: VEGF protein and its receptor proteins in pterygia: immunhistochmical localization and Western blot analysis. 98th Annual Meeting DOG, K 594, Berlin, Germany.
32. Solomon, A., D. Q. Li, S. b. Lee, and S. C. Tseng, 2000: Regulation of collagenase, stromelysin and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest. Ophthalmol. Vis. Sci. 41, 2154-2163.
33. Tan, D. T. H., A. S. M. Lim, H-S. Goh, and D. R. Smith, 1997: Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J. Ophthal. 123, 404-405.
34. Taylor, H. R., S. K. West, F. S. Rosenthal, B. Munoz, H. S. Newland, and E. A. Emmet, 1989: Corneal changes associated with chronic UV irradiation. Arch. Ophthalmol. 107, 1481-1484.
35. Troutbeck, R., and L. Hirst, 2001: Review of treatment of pterygium in Queensland: 10 years after a primary survery. Clin. Exp. Ophthalmol. 29, 286-290.
36. Tsironi, S., E. Ioachim, M. Machera, M. Aspiotis, N. Agnantis, and K. Psillas, 2002: Immunohistochemical HLA-DR antigen expression with lymphocyte subsets proliferative activity in pterygium. In Vivo 16, 299-306.
37. Valter, M. M., A. Hugel, H. J. Huang, W. K. Cavenee, O. D. Wiestler, T. Pietsch, and N. Wernert, 1999: Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (FIt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res. 59, 5608-5614.
38. Vass, Z., and I. Tapasztó, 1964: The histochemical examination of the fibers of pterygium by elastase. Acta Ophthal. 42, 849-853.
39. Wernert, N., M. B. Raes, P. Lassalle, M-P. Dehouck, B. Gosselin, B. Vanden-bunder, and D. Stehelin, 1992: The c-ETS 1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140, 119-127.
40. Wernert, N., F. Gilles, V. Fafeur, F. Bouali, M-B. Raes, C. Pyk, T. Dupressoir, and G. Seitz, 1994: Stromal expression of c-ETS 1 transcription factor correlates with tumor invasion. Cancer Res. 54, 5683-5688.
41. Wernert, N., A. Stanjek, S. Kiriakidis, A. Hugel, H. C. Jha, R. Mazitschek, and A. Giannis, 1999: Inhibition of angiogenesis in vivo by ets-1 antisense oligo-nucleotides - inhibition of Ets-1 transcription factor expression by the antibiotic fumagillin. Angew Chem. Int. Ed. Engl. 38, 3228-3231.
42. Wong, W. W., 1978: A hypothesis on the pathogenesis of pterygium. Ann. Ophthalmol. 10, 303-308.